Company Research Report on Ricovr Healthcare
Company Overview
- Name: Ricovr Healthcare
- Mission: The mission of Ricovr Healthcare is to revolutionize point-of-care diagnostics with unique technology, making accurate and rapid testing accessible to all. Ricovr aims to ensure safer workplaces for employees and employers and advance the healthcare industry.
- Founded: No information is available.
- Founders: Dr. Himanshu Bhatia is mentioned as the Founder & CEO.
- Key People:
- Dr. Himanshu Bhatia - Founder & CEO
- Dr. Joseph Seimetz - Director of Research and Development
- Pratik Patel - CMO
- Headquarters: 303A College Rd E, Princeton, NJ 08540, USA
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: Ricovr Healthcare is best known for its creation of the XALIVA® rapid diagnostics platform, a point-of-care diagnostic tool using a portable nanoparticle detection technology for applications like drug testing, among others.
Products
XALIVA® Rapid Diagnostics Platform
- High-Level Description: XALIVA® is a state-of-the-art rapid diagnostics platform for point-of-care testing, utilizing nanoparticle detection technology. It offers a portable, non-invasive, and efficient solution for various diagnostic needs, from drug testing to reproductive health.
- Key Features:
- Measures and displays results on-screen.
- Ultra-sensitive to the nanogram level.
- Rapid results within 15 minutes.
- Portable handheld device and disposable kit.
- Easy to use with just a few drops of saliva.
- Intuitive sample collection and testing workflow.
- Cost-effective solution for companies and testing administrators.
Recent Developments
- New Products or Features:
- Recently, Ricovr Healthcare secured a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to advance their cannabis screening device, strengthening its accurate point-of-care THC detection capabilities.
- XALIVA THC has been validated with successful external testing at Rutgers University demonstrating high accuracy in detecting THC in human saliva compared to gold standard methods.
- Partnerships and Collaborations:
- Collaborative efforts with Rutgers University have validated Ricovr's P-FAB technology using mass spectrometry for THC detection.
- The company maintains partnerships with leading research institutions and medical device manufacturing companies worldwide.
- Awards and Recognition:
- Secured NIH grant to further develop the XALIVA® platform.
- Recognized as one of the top ten promising companies in the U.S. at the GEC+ Event in Puerto Rico.
- Awarded a Maternal and Infant Health R&D grant by the State of New Jersey to support the development of diagnostic technologies focused on reproductive health.
- Noteworthy Events:
- Selected to present at the Global Entrepreneurship Congress (GEC+) event in Puerto Rico, showcasing their innovative Xaliva THC solution.
Contact Information
- Email: info@ricovr.com
- Address: 303A College Rd E, Princeton, NJ 08540, USA
- Social Media:
- [Facebook](#)
- [Twitter](#)
- [LinkedIn](#)
Note: This report only includes information from the provided data, and details that were not available within the data have been marked as "No information is available."
